Firm Blog

Ongoing FDA Safety Review Reveals Increased Risk of Bladder Cancer for Actos Users

According to the American Diabetes Association, millions of people have been diagnosed with type 2 diabetes in the U.S. Actos, or pioglitazone, is manufactured by the Takeda Pharmaceutical Company and is used to help regulate blood sugar in adults with type 2 diabetes mellitus. Based on data provided by the U.S. Food and Drug Administration (FDA), from
Read More

National Down Syndrome Congress Annual Convention Welcomed New Jersey Participants

The 39th Annual National Down Syndrome Congress (NDSC) Convention was held August 5-7, 2011 in San Antonio, Texas. Thousands of individuals from throughout the United States attended the convention to learn more about the latest information and research on Down Syndrome. One person attending the conference described it as inspiring and exhilarating. It was noted
Read More

Toms River Oncologist Loses Medical License Following Hepatitis B Outbreak

After a medical license suspension of over two years, the New Jersey Board of Medical Examiners revoked the license of Dr. Parvez Dara for a total of four years and fined him $30,000 in civil penalties due to “gross and repeated acts of negligence,” according to NJ.com. Because his license had already been suspended, however, he
Read More

Pottery Barn Kids Recall on Dolls Due to Strangulation Hazard

The U.S. Consumer Product Safety Commission (CPSC), in cooperation with Pottery Barn Kids, has announced the voluntary recall of approximately 81,000 Sophie, Chloe, and Audrey soft dolls due to a strangulation hazard caused by large loops in the dolls’ hair. There have been five reports of this defect and, although there have been no reported
Read More

Recognizing the Threat of Ovarian Cancer During Ovarian Cancer Awareness Month

Ovarian cancer is the fifth-leading cause of cancer-related deaths in women between the ages of 35 and 74, according to the National Ovarian Cancer Coalition (NOCC). In addition, the American Cancer Society estimates that 21,990 women will be newly diagnosed with ovarian cancer and another 15,460 will die from ovarian cancer in 2011. A woman’s chances
Read More